2010
DOI: 10.1016/j.actbio.2010.03.010
|View full text |Cite
|
Sign up to set email alerts
|

Bioengineering of the silica-polymerizing enzyme silicatein-α for a targeted application to hydroxyapatite

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
31
0
1

Year Published

2011
2011
2016
2016

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 43 publications
(33 citation statements)
references
References 57 publications
1
31
0
1
Order By: Relevance
“…These types of surfaces are of high interest for the tissue engineering field since they can be used to promote new bone formation [69]. This process can now be performed under physiologically relevant conditions [70]. This was achieved with the modification of the protein with a sequence that renders it binding affinity to hydroxyapatite (HA).…”
Section: Surface Modification For Medical Applicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…These types of surfaces are of high interest for the tissue engineering field since they can be used to promote new bone formation [69]. This process can now be performed under physiologically relevant conditions [70]. This was achieved with the modification of the protein with a sequence that renders it binding affinity to hydroxyapatite (HA).…”
Section: Surface Modification For Medical Applicationsmentioning
confidence: 99%
“…Due to these properties, this bioengineered silicatein presents important biomedical potential in the development of novel bioactive bone replacement materials or in the regeneration of bone defects. In addition, tooth surface defects and dentinal tubules could be corrected by the use of immobilized silicatein-synthesized biosilica layers [70].…”
Section: Surface Modification For Medical Applicationsmentioning
confidence: 99%
“…Since then, silicatein and its silicate substrate have been applied in vivo in a poly(D,L-lactide)/ poly(vinyl pyrrolidone)-based matrix as a prototypic implant material [20]. Concurrently, genetic modification of silicatein has extended the spectrum of possible biomedical application of biosilica: silicatein was fused to a biomimetic protein tag (Glutag) that conferred HA binding affinity and, hence, facilitated the coating of HA substrates with biosilica [21]. Finally, a new polyurethane dimethacrylate/methacryloxypropyltrimethoxysilane (PUD-MA-co-MPS) copolymer was synthesized and functionalized with biosilica through the polycondensation activity of immobilized silicatein to obtain an osteogenic surface coating, using both soluble orthosilicate as well as silanol groups on the copolymer surface as enzyme substrate [22].…”
Section: Introductionmentioning
confidence: 99%
“…The cDNAs, SDNOSIP-r and SDGNB-Trans, were amplified by standard polymerase chain reaction (PCR) as described (Natalio et al 2010). …”
Section: Preparation Of Recombinant Nosip and Tblr Protein And Antibomentioning
confidence: 99%